|
Reference #:
2006-161
Inventors/Contributors
George Vasmatzis Ph.D., John C. Cheville M.D., Farhad Kosari Ph.D., Cemile D. Savci Heijink M.D., Eric W. Klee Ph.D., Jan Marie A. Willard Munz, Lori S. Tillmans
Description
Mayo Clinic researchers have identified a gene panel that correlates with systemic progression and death after prostatectomy in men with high grade prostate cancer.
Application
Prediction of prostate cancer outcome after prostatectomy.
Stage of Development
The gene panel was identified and validated in a 157-patient case-control study with survival or stage of progression as end points. An additional case-control validation study has been completed on an independent cohort of 57 high risk patients who underwent prostatectomy.
Patent Status
Pending |
|
Contact
Barbara A. Gamez Sims, Licensing Manager
gamezsims.barbara@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
MN BioBusiness Center
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 284-8171
Fax: (507) 284-5410
|
|
|
